10 Pulmonary Embolism Clinical Trials in Duarte, CA (2026)

Q: How do I join a clinical trial in Duarte?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you.

Recruiting Pulmonary Embolism Studies in Duarte

NCT04031677Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dediffer...

Duarte, CAPHASE3250 participantsEuropean Organisation for Research and Treatment of Cancer - EORTC

View Study Details

NCT04628767Recruiting

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoc...

Duarte, CAPHASE2131 participantsNational Cancer Institute (NCI)

View Study Details

NCT06731894Recruiting

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

This phase II trials evaluates how well different types of phytocannabinoids (cannabidiol \[CBD\] versus tetrahydrocannabinol \[THC\] and CBD formulation \[THC:CBD\]) work to reduce chronic chemothera...

Duarte, CAPHASE2120 participantsCity of Hope Medical Center

View Study Details

NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

Duarte, CAPHASE352 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT06524960Recruiting

Denosumab for Type 1 Diabetes

Type 1 diabetes (T1D) arises from abnormal immune cell-mediated injury to beta cells that make insulin. The injured beta cells can then no longer make the needed amount of insulin to stay healthy. How...

Duarte, CAPHASE145 participantsCity of Hope Medical Center

View Study Details

NCT07365306Recruiting

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

This phase II trial tests how well epcoritamab in combination with rituximab, gemcitabine and oxaliplatin (R-GemOx) works as treatment given after the cancer has not responded to other treatments (sal...

Duarte, CAPHASE243 participantsCity of Hope Medical Center

View Study Details

NCT07293403Recruiting

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

This phase II trial tests how well duvelisib works as treatment that is given to help keep cancer from coming back after it has disappeared following the initial therapy (maintenance) for patients wit...

Duarte, CAPHASE225 participantsCity of Hope Medical Center

View Study Details

NCT07278856Recruiting

Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas

This phase I trial tests the safety, side effects and best dose of ruxolitinib in combination with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) chemotherapy and how well the combinati...

Duarte, CAPHASE120 participantsCity of Hope Medical Center

View Study Details

NCT03746769Recruiting

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

This clinical study will evaluate the safety and effectiveness of Gastrin treatment with islet transplantation to help patients with difficult to control type 1 diabetes make insulin again and improve...

Duarte, CAPHASE120 participantsCity of Hope Medical Center

View Study Details

NCT06919354Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell the...

Duarte, CAPHASE116 participantsGentiBio, Inc

View Study Details

About Pulmonary Embolism Clinical Trials in Duarte

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 10 pulmonary embolism clinical trials recruiting participants in Duarte, CA. These studies are seeking a combined 722 participants. Research is being sponsored by European Organisation for Research and Treatment of Cancer - EORTC, National Cancer Institute (NCI), City of Hope Medical Center and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Duarte — FAQ

Are there pulmonary embolism clinical trials in Duarte?

Yes, there are 10 pulmonary embolism clinical trials currently recruiting in Duarte, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Duarte?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Duarte research site will contact you about next steps.

Are clinical trials in Duarte free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Duarte studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 10 active trials in Duarte are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 17, 2026 from ClinicalTrials.gov